These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38127169)

  • 41. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support.
    Jump RL; Robinson ME; Armstrong AE; Barnes EV; Kilbourn KM; Richards HB
    J Rheumatol; 2005 Sep; 32(9):1699-705. PubMed ID: 16142863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceived Stress and Prediction of Worse Disease Activity and Symptoms in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort.
    Patterson S; Trupin L; Hartogensis W; DeQuattro K; Lanata C; Gordon C; Barbour KE; Greenlund KJ; Dall'Era M; Yazdany J; Katz P
    Arthritis Care Res (Hoboken); 2023 Aug; 75(8):1681-1689. PubMed ID: 36537191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus.
    Katz P; Pedro S; Alemao E; Yazdany J; Dall'Era M; Trupin L; Rush S; Michaud K
    ACR Open Rheumatol; 2020 Jan; 2(1):53-60. PubMed ID: 31943975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
    Kim SK; Choe JY; Lee SS
    Yonsei Med J; 2018 Sep; 59(7):857-864. PubMed ID: 30091319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
    Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB
    Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).
    Rendas-Baum R; Baranwal N; Joshi AV; Park J; Kosinski M
    J Patient Rep Outcomes; 2021 Apr; 5(1):33. PubMed ID: 33830377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus.
    Giangreco D; Devilliers H; Annapureddy N; Block JA; Jolly M
    Lupus; 2015 Dec; 24(14):1486-91. PubMed ID: 26162686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
    Thanou A; Chakravarty E; James JA; Merrill JT
    Rheumatology (Oxford); 2014 Dec; 53(12):2175-81. PubMed ID: 24729400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychological distress and changes in the activity of systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    Rheumatology (Oxford); 2002 Feb; 41(2):184-8. PubMed ID: 11886968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease-specific quality of life in patients with lupus nephritis.
    Jolly M; Toloza S; Goker B; Clarke AE; Navarra SV; Wallace D; Weisman M; Mok CC
    Lupus; 2018 Feb; 27(2):257-264. PubMed ID: 28728507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatigue in systemic lupus erythematosus : Association with disease activity, quality of life and psychosocial factors.
    Yilmaz-Oner S; Ilhan B; Can M; Alibaz-Oner F; Polat-Korkmaz O; Ozen G; Mumcu G; Kremers HM; Tuglular S; Direskeneli H
    Z Rheumatol; 2017 Dec; 76(10):913-919. PubMed ID: 27600110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus.
    Eudy AM; Clowse ME; Corneli A; McKenna K; Pisetsky DS; Maheswaranathan M; Burshell D; Doss J; Sun K; Sadun RE; Criscione-Schreiber LG; Rogers JL
    Lupus; 2024 Mar; 33(3):266-272. PubMed ID: 38238905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients.
    Tani C; Vagelli R; Stagnaro C; Carli L; Lorenzoni V; Drago F; Doherty W; McSorley MR; Marconcini L; Della Rossa A; Turchetti G; Mosca M
    Lupus; 2018 Sep; 27(10):1735-1741. PubMed ID: 30045666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
    Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
    Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of the Patient-Reported Outcomes Measurement Information System 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus.
    Katz P; Pedro S; Michaud K
    Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1312-1321. PubMed ID: 28029753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.